- Hubei Weikang Protective Products Co., Ltd.
- Issuing Office:
Department of Health and Human Services
|Public Health Service|
Food and Drug Administration
|10903 New Hampshire Avenue|
Silver Spring, MD 20993
DEC 27, 2016
Hubei Weikang Protective Products Co., Ltd.
GongQing ChuangYe Industrial Zone, Yewang Road
Xiantao City, Hubei1 433000
Dear Mr. Yang:
The Food and Drug Administration (FDA) has completed an evaluation of your firm's corrective actions in response to our Warning Letter (CMS #478843, dated October 2, 2015). Based on our evaluation, it appears that your firm has adequately addressed the violations contained in this Warning Letter.
This letter does not relieve your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations. The FDA expects your firm to maintain compliance and this letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
M. Isabel Tejero del Rio, MD PhD
Division of International Compliance Operations
Office of Compliance
Center for Devices and Radiological Health
144 Research Drive
Hampton, UT 23666